Publications
Author Correction: Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy." Nature Communications 14, no. 1 (2023).
"Conserved chamber-specific polyploidy maintains heart function in Drosophila." Development 150, no. 16 (2023).
"Differential Response of Engineered Human Cardiac Tissues to Delta and Omicron COVID-19 Virus." Journal of the American Heart Association 12, no. 12 (2023).
"An enhancer-based gene-therapy strategy for spatiotemporal control of cargoes during tissue repair." Cell Stem Cell 30, no. 1 (2023): 96-111.e6.
"Prokaryotic voltage-gated sodium channels are more effective than endogenous Nav1.5 channels in rescuing cardiac action potential conduction: an in silico study." American Journal of Physiology Heart and Circulatory Physiology 325, no. 5 (2023): H1178-H1192.
" "
BRG1 is a biomarker of hypertrophic cardiomyopathy in human heart specimens." Scientific Reports 12, no. 1 (2022).
"CRISPR Library Screening in Cultured Cardiomyocytes." Methods in Molecular Biology (Clifton, N.J.) 2485 (2022): 1-13.
"Differential microRNA profiles of intramuscular and secreted extracellular vesicles in human tissue-engineered muscle." Frontiers in Physiology 13 (2022).
"Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy." Nature Communications 13, no. 1 (2022).
"Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction." Cell Stem Cell 29, no. 2 (2022): 281-297.e12.
"Meteorin-like is an injectable peptide that can enhance regeneration in aged muscle through immune-driven fibro/adipogenic progenitor signaling." Nature Communications 13, no. 1 (2022).
"Myoblast deactivation within engineered human skeletal muscle creates a transcriptionally heterogeneous population of quiescent satellite-like cells." Biomaterials 284 (2022): 121508.
"Targeted Delivery for Cardiac Regeneration: Comparison of Intra-coronary Infusion and Intra-myocardial Injection in Porcine Hearts." Frontiers in Cardiovascular Medicine 9 (2022).
"Toward improved understanding of cardiac development and congenital heart disease: The advent of cardiac organoids." The Journal of Thoracic and Cardiovascular Surgery 164, no. 6 (2022): 2013-2018.
"Translating musculoskeletal bioengineering into tissue regeneration therapies." Science Translational Medicine 14, no. 666 (2022).
"Exercise mimetics and JAK inhibition attenuate IFN-γ-induced wasting in engineered human skeletal muscle." Science Advances 7, no. 4 (2021).
" "Frame-Hydrogel Methodology for Engineering Highly Functional Cardiac Tissue Constructs." Methods in Molecular Biology (Clifton, N.J.) 2158 (2021): 171-186.
"Human Erbb2-induced Erk activity robustly stimulates cycling and functional remodeling of rat and human cardiomyocytes." Elife 10 (2021).
"In vitro discovery of novel prokaryotic ion channel candidates for antiarrhythmic gene therapy.. Vol. 654., 2021.
Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium." Acta Biomaterialia 126 (2021): 144-153.
"Neuromuscular Development and Disease: Learning From in vitro and in vivo Models." Frontiers in Cell and Developmental Biology 9 (2021).
"The NIH Somatic Cell Genome Editing program." Nature 592, no. 7853 (2021): 195-204.
"Single Vector AAV Approach to Genome Editing in Pompe Disease." In Molecular Therapy, 291. Vol. 29. 2021.
"